Chartwell Investment Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $717K | Buy |
18,213
+144
| +0.8% | +$5.67K | 0.02% | 377 |
|
|
2024
Q2 | $705K | Sell |
18,069
-2,951
| -14% | -$115K | 0.02% | 374 |
|
|
2024
Q1 | $905K | Buy |
21,020
+500
| +2% | +$21.5K | 0.03% | 373 |
|
|
2023
Q4 | $945K | Sell |
20,520
-2,781
| -12% | -$128K | 0.03% | 365 |
|
|
2023
Q3 | $796K | Hold |
23,301
| – | – | 0.03% | 367 |
|
|
2023
Q2 | $897K | Buy |
23,301
+1,133
| +5% | +$43.6K | 0.03% | 359 |
|
|
2023
Q1 | $793K | Sell |
22,168
-1,462
| -6% | -$52.3K | 0.03% | 362 |
|
|
2022
Q4 | $932K | Buy |
23,630
+1,341
| +6% | +$52.9K | 0.04% | 347 |
|
|
2022
Q3 | $805K | Buy |
22,289
+781
| +4% | +$28.2K | 0.03% | 361 |
|
|
2022
Q2 | $654K | Buy |
+21,508
| New | +$654K | 0.03% | 383 |
|